Skip to main content

Table 3 Clinical and therapeutic features of studied cases

From: Clinical profile and outcome of acute organophosphate poisoning in children of Upper Egypt: a cross-sectional study

Variable

Total patients

(n = 108) n (%)

Severity of poisoning

 Mild (grade 1)

19 (17.5%)

 Moderate (grade 2)

46 (42.5%)

 Severe (grade 3)

43 (40%)

Time to presentation

 ≤ 6 h

43 (40%)

 >  6 h

65 (60%)

Consciousness and brain injury status

 Conscious

42 (39%)

 Mild brain injury (GCS 13–15)

24 (22. 2%)

 Moderate brain injury (GCS 9-12)

13 (12%)

 Sever brain injury (GCS ≤ 8)

29 (26.8%)

Common clinical manifestations at presentation

 Miosis

108 (100%)

 Respiratory distress

84 (77.7%)

 Vomiting

47 (43.5%)

 Bradycardia

36 (33. 3%)

 Sweating

17 (15.7%)

 Convulsion

15 (13.8%)

 Muscle weakness

12 (11. 1%)

 Fasciculations

9 (8%)

Complications

 Respiratory failure

14 (13%)

 Aspiration pneumonia

5 (4.6%)

 Septicemia

3 (2.8%)

 Acute renal failure

1 (0.9%)

Use of atropine (all cases)

 Initial at emergency

0. 2–0.8 mg

 Cumulative dose

1.33 ± 0.52 mg

Use of pralidoxime (9 cases)

 Initial at emergency

0. 5-1g

 Cumulative dose

13.95 ± 5.04 g

Need for Mechanical ventilation

14 (13%)

Decontamination (charcoal &gastric lavage)

39 (36. 1%)

  1. GCS Glasgow coma scale